• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于气相色谱-质谱联用技术的代谢组学鉴定外周血单核细胞中可能用于精神分裂症的新型生物标志物

GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells.

作者信息

Liu Mei-Ling, Zheng Peng, Liu Zhao, Xu Yi, Mu Jun, Guo Jing, Huang Ting, Meng Hua-Qing, Xie Peng

机构信息

Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Yuzhong District, Chongqing, P. R. China 400016.

出版信息

Mol Biosyst. 2014 Jul 29;10(9):2398-406. doi: 10.1039/c4mb00157e.

DOI:10.1039/c4mb00157e
PMID:24975926
Abstract

Schizophrenia is a debilitating mental disorder. Currently, the lack of disease biomarkers to support objective laboratory tests constitutes a bottleneck in the clinical diagnosis of schizophrenia. Here, a gas chromatography-mass spectrometry (GC-MS) based metabolomic approach was applied to characterize the metabolic profile of schizophrenia subjects (n = 69) and healthy controls (n = 85) in peripheral blood mononuclear cells (PBMCs) to identify and validate biomarkers for schizophrenia. Multivariate statistical analysis was used to visualize group discrimination and to identify differentially expressed metabolites in schizophrenia subjects relative to healthy controls. The multivariate statistical analysis demonstrated that the schizophrenia group was significantly distinguishable from the control group. In total, 18 metabolites responsible for the discrimination between the two groups were identified. These differential metabolites were mainly involved in energy metabolism, oxidative stress and neurotransmitter metabolism. A simplified panel of PBMC metabolites consisting of pyroglutamic acid, sorbitol and tocopherol-α was identified as an effective diagnostic tool, yielding an area under the receiver operating characteristic curve (AUC) of 0.82 in the training samples (45 schizophrenia subjects and 50 healthy controls) and 0.71 in the test samples (24 schizophrenic patients and 35 healthy controls). Taken together, these findings help to develop diagnostic tools for schizophrenia.

摘要

精神分裂症是一种使人衰弱的精神障碍。目前,缺乏支持客观实验室检测的疾病生物标志物构成了精神分裂症临床诊断的瓶颈。在此,基于气相色谱-质谱联用(GC-MS)的代谢组学方法被用于表征精神分裂症患者(n = 69)和健康对照者(n = 85)外周血单核细胞(PBMCs)的代谢谱,以识别和验证精神分裂症的生物标志物。多变量统计分析用于直观显示组间差异,并识别精神分裂症患者相对于健康对照者中差异表达的代谢物。多变量统计分析表明,精神分裂症组与对照组有显著差异。总共鉴定出18种导致两组间差异的代谢物。这些差异代谢物主要参与能量代谢、氧化应激和神经递质代谢。由焦谷氨酸、山梨醇和α-生育酚组成的简化PBMC代谢物组被确定为一种有效的诊断工具,在训练样本(45例精神分裂症患者和50例健康对照者)中的受试者工作特征曲线下面积(AUC)为0.82,在测试样本(24例精神分裂症患者和35例健康对照者)中为0.71。综上所述,这些发现有助于开发精神分裂症的诊断工具。

相似文献

1
GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells.基于气相色谱-质谱联用技术的代谢组学鉴定外周血单核细胞中可能用于精神分裂症的新型生物标志物
Mol Biosyst. 2014 Jul 29;10(9):2398-406. doi: 10.1039/c4mb00157e.
2
Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells.外周血单个核细胞中用于诊断重度抑郁症的代谢物特征
J Affect Disord. 2016 May;195:75-81. doi: 10.1016/j.jad.2016.02.008. Epub 2016 Feb 5.
3
2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder.2,4-二羟基嘧啶是一种用于诊断双相情感障碍的潜在尿液代谢物生物标志物。
Mol Biosyst. 2014 Apr;10(4):813-9. doi: 10.1039/c3mb70614a. Epub 2014 Jan 24.
4
A novel urinary metabolite signature for diagnosing major depressive disorder.一种用于诊断重度抑郁症的新型尿代谢物特征。
J Proteome Res. 2013 Dec 6;12(12):5904-11. doi: 10.1021/pr400939q. Epub 2013 Nov 26.
5
Severe disturbance of glucose metabolism in peripheral blood mononuclear cells of schizophrenia patients: a targeted metabolomic study.精神分裂症患者外周血单个核细胞中葡萄糖代谢的严重紊乱:一项靶向代谢组学研究。
J Transl Med. 2015 Jul 14;13:226. doi: 10.1186/s12967-015-0540-y.
6
Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.采用气相色谱-质谱联用和核磁共振光谱代谢组学方法鉴定重度抑郁症和双相情感障碍之间不同的尿液代谢表型。
J Proteome Res. 2015 Aug 7;14(8):3382-9. doi: 10.1021/acs.jproteome.5b00434. Epub 2015 Jul 20.
7
Peripheral blood mononuclear cell-based metabolomic profiling of a chronic unpredictable mild stress rat model of depression.基于外周血单个核细胞的慢性不可预测轻度应激抑郁大鼠模型的代谢组学分析
Mol Biosyst. 2014 Nov;10(11):2994-3001. doi: 10.1039/c4mb00388h.
8
Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action.代谢组学分析鉴定精神分裂症及利培酮作用的潜在血清生物标志物
J Proteome Res. 2011 Dec 2;10(12):5433-43. doi: 10.1021/pr2006796. Epub 2011 Nov 8.
9
Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naïve schizophrenia patients after treatment with risperidone.利培酮治疗首发未经抗精神病药物治疗的精神分裂症患者后血浆和尿液中生化变化的代谢组学分析。
J Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul 26.
10
Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.使用气相色谱/质谱法建立食管癌诊断模型的代谢组学研究
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Oct 1;877(27):3111-7. doi: 10.1016/j.jchromb.2009.07.039. Epub 2009 Aug 7.

引用本文的文献

1
Validated metabolomic biomarkers in psychiatric disorders: a narrative review.精神疾病中经过验证的代谢组学生物标志物:一项叙述性综述。
Mol Med. 2025 Jul 9;31(1):254. doi: 10.1186/s10020-025-01258-7.
2
Discovery of biological markers for schizophrenia based on metabolomics: a systematic review.基于代谢组学的精神分裂症生物标志物发现:一项系统综述
Front Psychiatry. 2025 Mar 28;16:1540260. doi: 10.3389/fpsyt.2025.1540260. eCollection 2025.
3
Peripheral Lipid Signatures, Metabolic Dysfunction, and Pathophysiology in Schizophrenia Spectrum Disorders.
精神分裂症谱系障碍中的外周脂质特征、代谢功能障碍与病理生理学
Metabolites. 2024 Aug 28;14(9):475. doi: 10.3390/metabo14090475.
4
Metabolomic analysis of swainsonine poisoning in renal tubular epithelial cells.肾小管上皮细胞中苦马豆素中毒的代谢组学分析
Front Vet Sci. 2024 May 21;11:1387853. doi: 10.3389/fvets.2024.1387853. eCollection 2024.
5
Downregulation of mGluR1-mediated signaling underlying autistic-like core symptoms in Shank1 P1812L-knock-in mice.Shank1 P1812L 敲入小鼠自闭症核心症状相关的 mGluR1 介导的信号下调。
Transl Psychiatry. 2023 Oct 25;13(1):329. doi: 10.1038/s41398-023-02626-9.
6
Qualitative and Quantitative Mass Spectrometry in Salivary Metabolomics and Proteomics.唾液代谢组学和蛋白质组学中的定性和定量质谱分析
Metabolites. 2023 Jan 20;13(2):155. doi: 10.3390/metabo13020155.
7
Experiences and Perspectives of GC-MS Application for the Search of Low Molecular Weight Discriminants of Schizophrenia.GC-MS 应用于寻找精神分裂症低分子量标志物的经验和观点。
Molecules. 2022 Dec 31;28(1):324. doi: 10.3390/molecules28010324.
8
Metabolomic and proteomic profiling in bipolar disorder patients revealed potential molecular signatures related to hemostasis.双相障碍患者的代谢组学和蛋白质组学分析揭示了与止血相关的潜在分子特征。
Metabolomics. 2022 Aug 3;18(8):65. doi: 10.1007/s11306-022-01924-5.
9
Metabolomic biomarkers related to non-suicidal self-injury in patients with bipolar disorder.与双相障碍患者非自杀性自伤相关的代谢组学生物标志物。
BMC Psychiatry. 2022 Jul 22;22(1):491. doi: 10.1186/s12888-022-04079-8.
10
Fluxomics - New Metabolomics Approaches to Monitor Metabolic Pathways.通量组学——监测代谢途径的新代谢组学方法
Front Pharmacol. 2022 Mar 21;13:805782. doi: 10.3389/fphar.2022.805782. eCollection 2022.